UPDATE: Citi Downgrades Vanda Pharmaceuticals (VNDA) to Neutral
Tweet Send to a Friend
(Updated - January 14, 2021 5:00 AM EST)
Citi analyst Joel Beatty downgraded Vanda Pharmaceuticals (NASDAQ: VNDA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Joel Beatty downgraded Vanda Pharmaceuticals (NASDAQ: VNDA) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
